2nd Tumor Myeloid-Directed Therapies Summit

Conference themes
Returning in 2022, the Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment.

This is your ultimate forum to identify, validate, and clinically progress myeloid targets to expand the oncologists toolkit and realize better responses by engaging myeloid anti-tumor function.

Professional congress organizer (PCO)
Hanson Wade

https://go.evvnt.com/1007623-1?pid=4832

Ms. Hollie Bulfin